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IDIOPATHIC HYPERLIPEMIA AND PRIMARY
HYPERCHOLESTEREMIC XANTHOMATOSIS*
III. EFFECTS OF INTRAVENOUSLY ADMINISTERED HEPARIN ON THE PLASMA
PROTEINS AND LIPIDS
WALTER F. LEVER, M.D., PETER A. J. SMITH, MB., M.R.C.P., AND NANCY A.
HTJRLEY, B.S.
Because heparin when administered intravenously is known to decrease the tur-
bidity existing in normal plasma during postalimentary hyperlipemia (1, 2) it
was thought of interest to study the effect of intravenously administered heparin
on the turbidity, the electrophoretic pattern and the various lipids of the plasma
of patients with primary hypercholesteremic xanthomatosis and idiopathic
hyperlipemia. Since significant changes in the electrophoretic pattern occurred
in both groups of patients and since electrophoretic analyses of the plasma of
normal individuals after the intravenous injection of heparin have been reported
so far in only one case the findings in a group of healthy persons are included in
this report.
REVIEW OF LITERATURE
In 1943, Hahn (1) first reported the observation that in dogs the turbidity of postali-
mentary hyperlipemia disappears within three to five minutes after an intravenous injec-
tion of heparin. Block, Barker and Mann (2) confirmed these findings in human beings
noting that maximum clearing of the plasma occurs fifteen minutes after the injection of
heparin. Using only 5 mg. of heparin for their experiments they observed no significant
changes in the values for the plasma lipids following the intravenous injection.
Nikkilk (3) studied the electrophoretic pattern of the serum in one normal individual,
first in the fasting state and then after a fatty meal followed by an intravenous injection
of heparin. He noted that following the injection of heparin the size of the beta peak de-
creased while the size of the alpha-i peak increased. Using paper electrophoresis and stain-
ing for lipids he observed a decrease of the lipid content in the beta and gamma regions and
an increase in the alpha-i and alpha-2 regions.
The effects of heparin on the plasma of patients with idiopathic hyperlipemia have been
studied by Joyner (4), by Klatskin and Gordon (5), and by Van Eck, Peters and Man (6).
Joyner (4) administered to 1 patient with idiopathic hyperlipemia 5 mg. of heparin intra-
venously following a fatty meal. He observed that in this patient, following the injection of
heparin, the postalimentary increase in turbidity decreased to a lesser degree than in 3
normal individuals whom he used as control. Klatskin and Gordon (5) studied the effects of
an intravenous injection of 50 mg. of heparin on the plasma lipids of idiopathic hyperlipemia
in 1 patient; and Van Eck, Peters and Man (6) did the same in 2 patients. Klatskin and Gor-
don noted in their patient fifteen minutes after the injection a perceptible decrease in the
turbidity of the plasma. In all 3 patients a decrease in fatty acids, varying from 4.9 to 6.3
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mEq./L., took place. This was regarded by the authors as beyond the experimental error.
On the other hand, the decrease in cholesterol, varying from 4 to 10 mg. per 100 ml., and
the decrease in phospholipids, varying from 12.5 to 25 mg., was regarded by the aut.hors as
within the experimental error and therefore as not significant.
It is beyond the scope of this communication to review the reports on the effects of
heparin on the lipids and lipoproteins in the plasma of patients with atherosclerosis. It may
be mentioned, however, that Block, Mann and Barker (2) observed that the turbidity of
postalimentary hyperlipemia did not clear as well in patients with atherosclerosis as in
normal individuals following the intravenous injection of 5 mg. of heparin. Furthermore,
Graham, Lyon, Gofman, Jones, Yankley, Simonton and White (7) observed in their studies
by ultracentrifuge that 100 mg. of heparin injected intravenously caused in patients with
atherosclerosis a profound reorientation in the distribution of low density lipoproteins,
characterized by a shift of lipoproteins of high S1 rates to those of successively lower S1
rates.
METHODS
Blood was obtained from each person in the fasting stage using for an anticoagulant acid
citrate dextrose solution as described in Part 1(8). Immediately thereafter heparin, usually
50 mg. and occasionally 100 mg., was injected intravenously. Fifteen minutes later another
sample of blood was taken, again using acid citrate dextrose as anticoagulant.
In order to correct for the dilution caused by the addition of the acid citrate dextrose
solution to the blood a small amount of blood was also drawn each time with a dry syringe
and placed in a tube containing a small amount of heparin powder. This was used for a
reference determination of nitrogen. All values obtained on the acid citrate dextrose plasma
were corrected by the factor (N in plasma with heparin powder/N in plasma with acid
citrate dextrose).
All chemical determinations were carried out as described in Part I (8) and Part II (9)
of this communication.
OBSERVATIONS
.1. Normal Individuals. Seven normal persons received 50 mg. of heparin
intravenously.
The amount of total protein decreased, following the injection of heparin, by
more than 0.4 gm. per 100 ml. in 3 persons (cases IV, V and VII) and remained
essentially unchanged in the others (Table 1).
Electrophoretic analyses of the plasma revealed no changes in 5 persons while
in 2 the size of the beta-i peak decreased considerably from a normal value to
less than half the normal value. Compensating for the decrease there was in one
person (case II) an increase in both the alpha-i and albumin peaks, and in the
other (case VI) an increase in the alpha-2 peak.
The degree of turbidity in the plasma decreased slightly in 6 of 7 persons, but
too slightly to be of real significance.
The values of the various lipids in the plasma decreased in some instances and
increased in others, but in most persons showed no significant change.
One individual in whom the electrophoretic pattern had shown no change
following the injection of 50 mg. of heparin (case III) showed no change either
when 100 mg. of heparin were injected.
. Primary Hypercholesteremic Xanthomatosis. Fight patients were tested by an
intravenous injection of 50 mg. of heparin.
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TABLE 1
Effects of an intravenous injection of heparin on the proteins, the turbidity and the
lipids in the plasma of normal individuals
-SUBJECT
I
STATE
OF
PLASISA
Nat.
Hep.
PROTEINS RELATIVE ELECTROPHOR. VALUES TUR-
BIDITY
FATTY
ACIDS
NEU-
TRAL
FAT
CHOLESTEROL
PHO
Ester- LIPIDS
ified
N N X
6.25 A 1 2 1 2** 13 /
gm/iSO ml. % of Total Protein units mg/lOS ml.
1.21
1.20
7.56
7.50
57.9
56.4
5.4
7.5
5.9
6.0
10.4
11.0
6.2
6.8
14.2
12.4
2.3
2.1
239
230
57
51
221
206
85
84
195
183
II
III
Nat.
Hep.
Nat.
Hep.
1.26
1.25
1.16
1.19
7.88
7.81
7.25
7.44
55.1
59.6
58.4
57.5
8.8
11.5
8.2
8.1
5.7
4.5
5.3
6.5
13.2
6.6
13.1
13.0
6.3
6.5
5.8
5.9
11.0
11.3
9.2
9.1
4.1
3.7
2.2
2.1
479
419
347
323
216
185
139
136
252
241
234
233
129
102
114
88
267
263
200
199
IV Nat.
Hep.
1.26
1.19
7.88
7.44
50.2
53.4
8.3
6.4
6.4
6.0
12.1
11.5
7.0
7.3
16.0
15.6
2.4
2.4
185
168
0
0
214
197
85
98
222
216
V
VI
VII
311*
Aver.
I—Vu
Nat.
Hep.
Nat.
HOP.
Nat.
Hep.
Nat.
Hep.
Nat.
Hep.
1.22 7.63
1.15 7.19
1.21 7.56
1.18 7.38
1.26 7.88
1.18 7.38
1.21 7.56
1.24 7.75
1.23 7.66
1.15 7.45
57.0
56.6
55.7
56.1
58.7
62.8
60.0
60.9
56.1
57.5
7.3
6.9
7.0
9.1
5.4
5.0
6.3
6.0
7.2
7.8
6.2
7.0
9.1
14.9
6.7
5.8
6.4
6.5
6.5
7.2
13.7 6.2
14.1 7.2
12.9 6.0
6.4 5.7
13.1 6.6
12.3 5.5
12.3 5.5
11.3 5.7
12.6 6.3
10.7 6.4
9.6
8.2
9.3
7.8
9.6
8.6
9.5
9.7
11.3
10.4
2.6
2.3
3.0
2.5
3.2
2.7
3.2
2.9
2.8
2.5
268
223
373
401
347
344
319
294
320
301
0
0
62
65
34
14
102
77
73
64
189
228
239
262
233
242
203
218
226
230
91
111
116
144
113
121
92
99
105
107
335
326
359
360
362
339
228
235
277
269
Nat.: Plasma in its native Stage.
Hep.: Plasma after the iv. injection of 50 mg. of heparin (* signifies 100 mg. of heparin).
The amount of total protein decreased by more than 0.4 gm. per 100 ml. in 3
patients (cases 11, 13 and 15), and did not change appreciably in 5 patients
(Table 2).
Electrophoretic analysis of the plasma revealed significant changes in 6 patients
and no changes in 2 patients (Table 2, cases 11 and 17). In the 6 patients the
beta-i peak, which in patients with primary hypercholesteremic xanthomatosis
is increased above its normal size, decreased considerably (Figure 1), from an
average of 16.8 per cent to 7 per cent of the total protein, a value far below the
normal average value of 13 per cent. Corresponding to the decrease in the size
of the beta-i peak either the alpha-2 peak alone (cases 12, 13 and 15), the albumin
peak alone (case 16), or both the alpha-2 and albumin peaks (cases 9 and 14)
increased in size to values well above normal.
The values for turbidity which were within the normal range (1 to 5 units)
in all patients decreased in 2 patients by 1.0 and 0.7 units, respectively (cases 9
and 16) and did not change significantly in the other 6 patients. It is possible
that the 2 patients in whom a decrease occurred were not strictly fasting at the
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TABLE 2
Effects of an intravenous injection of heparin on the proteins, the turbidity and the
lipids in plasma of patients with primary hypercholesteremic xanthomatosis
RELATIVE ELECTEOPHOR. VALUES
TUE- FATTY NEU- STEROL pnos.
STATE —_________________________ I TEAL —.-- PRO-BIDITY ACIDS —
PATIENT OP N N X FAT J Ester- LIPIDS
PLASMA 6.25 A a-i "-2 5-2 itled
gm/lot ml. % of Total Protein units mg/tOO ml.
9 Nat. 1.27 7.94 46.1 8.2 9.5 15.1 9.9 11.2 4.2 tie 298 324 565 286
Eep. 1.24 7.75 53.7 6.8 12.8 8.5 7.5 10.5 3.2 476 190 291 136 270
11 Nat. 1.33 8.31 41.8 6.7 8.8 20.4 10.4 U.S 3.3 550 133 028 264 360
Rep. 1.26 7.90 41.9 5.4 10.4 20.5 10.3 I 11.6 3.7 654 264 506 244 339
12 Nat. 1.23 7.69 50.7 9.5 6.6 15.7 6.3 11.2 3.5 t02 219 389 197 386
Hep. 1.21 7.56 54.0 6.1 17.8 5.3 5.8 10.9 3.0 t55 293 378 198 346
13 Nat. 1.20 7.50 45.8 6.6 8.3 18.4 6.8 14.2 2.6 733 372 480 264 260
Eep. 1.09 6.81 47.9 6.9 17.6 6.4 7.7 13.6 2.7 t42 280 459 266 282
14 Nat. 1.18 7.38 46.5 6.0 9.8 18.6 6.4 12.6 2.7 711 190 500 336 445
Rep. 1.14 7.13 52.4 6.1 14.7 7.5 6.4 12.9 2.5 719 239 485 302 425
10 Nat. 1.18 7.38 49.4 4.1 8.0 16.8 7.5 14.3 3.2 479 94 425 260 313
Hep. 1.11 6.94 47.6 9.1 19.3 6.9 8.0 13.2 2.9 493 99 400 244 341
16 Nat. 1.32 8.20 43.5 5.7 ss 16.1 10.6 14.7 3.9 581 264 381 200 273
Rep. 1.32 8.20 59.1 5.1 6.6 7.2 9.0 13.1 3.2 553 236 372 214 266
17 Nat. 1.30 8.13 40.2 5.2 7.0 18.0 6.5 22.5 3.7 657 213 477 264 393
Rep. 1.31 8.19 39.3 6.5 7.1 17.7 7.6 21.8 3.8 616 106 442 262 429
Aver. F Nat. 1.25 7.82 45.5 6.5 9.4 17.5 6.1 14.1 3.4 616 223 444 244 342
Rep. 1.21 7.57 49.5 6.0 13.3 10.0 7.6 13.5 3.1 601 220 417 233 338
Nat.: Plasma in its native state.
Rep.: Plasma after tile iv. injection of 50mg. of heparin.
Fin. 1. Electrophoretic patterns of the plasma of Patient 14 with primary hypercholes-
teremic xanthomatosis. Left, native p]asma: the beta-i peak is elevated. Right, plasma
takesi fifteen minutes after the intravenous injection of 50 mg. of heparin. The beta-l peak
now is smaller than normal in size, while the alpha-2 peak has increased in size.
Aa1a2$1$2y Aa1a2$1y
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time blood was drawn for analysis since their values for turbidity before the
administration of heparin were slightly higher than those in the other patients.
Of the values for the various lipids those of the total cholesterol were the only
ones which consistently showed a decrease in all 8 patients. Although a decrease
exceeding 20 mg. occurred only in 4 patients (cases 9, 11, 15 and 17) the con-
sistency of the decrease in all patients makes it significant. The decrease affected
in some patients predominantly the free cholesterol and in others the esterifled
cholesterol. The phospholipids showed no consistent changes, showing a decrease
in 3, an increase in 2 and no significant change in 3 patients. Similarly the values
for neutral fat reacted inconsistently, showing a decrease in 3, an increase in 3,
and no significant change in 2 patients.
No correlation existed between the changes in the electrophoretic pattern and
those of the lipids. It is of interest that in the 2 patients (cases 11 and 17) in
whom no change occurred in the electrophoretic pattern the values for cholesterol
decreased significantly.
3. Idiopathic Hyperlipemia. The plasma of 7 patients with idiopathic hyper-
lipemia showed even more pronounced changes following the injection of heparin
than the plasma of the normal individuals and of those with primary hyper-
cholesteremic xanthomatosis.
The amount of total protein, following the injection of heparin, decreased by
more than 0.4 gm. in 4 patients (cases 1, 4, 5 and 7) while it did not change signifi-
cantly in the 3 others (Table 3).
Electrophoretic analyses revealed a most interesting effect of the heparin on the
elevated lipid peaks in 6 of the 7 patients. In these 6 patients the native plasma
showed either an elevation of the alpha-2 peak only (cases 1, 2 and 3) (Figure 2a),
of the alpha-2 and beta-i peaks as separate peaks (cases 6 and 7), or of the alpha-
2 and beta-i peaks as one inseparable peak (case 4) (Figure 3a) (case 4). After
the intravenous injection of heparin these elevated peaks had decreased to normal
size and, instead, a new component had appeared ahead of the albumin peak
(Figures 2b and 3b). The only patient in whom this pre-albumin component was
not noted was patient 5 who also otherwise differed in his response to heparin
(see below). The new pre-albumin component present after the injection of
heparin had a jagged appearance (Figures 2b, 3b, 4e) caused by the presence of
large lipid particles (chylomicra) in that region producing spurious refractive
index gradients. This jagged outline made an exact measuring of the pre-albumin
peak impossible and the values obtained (Table 3) represent merely approxima-
tions. The highest value obtained for this pre-albumin component when 50 mg.
of heparin were injected was 16.9 per cent of the total protein in case 1 (Figure
4e). In the other 5 patients in whom the electrophoretic pattern could be calcu-
lated the values were 11.9 per cent (Figure 2h), 9 per cent (Figure 3b), 6.5 per
cent and 3.7 per cent, respectively. In one patient (case 2) the plasma was too
turbid to calculate the size of the pre-albumin peak or of any other peak. In 1
patient (case 6) an increase in the dosage of heparin from 50 to 100 mg. caused
a considerable increase in size of the pre-albumin peak from 3.7 to 21.0 per cent
of the total protein. Observation of the developing electrophoretic pattern during
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FIG. 2. Electrophoretic patterns of the plasma of Patient 3 with idiopathic hyperlipemia.
Left, native plasma: the alpha-2 peak is greatly elevated. Right, plasma fifteen minutes
after the intravenous injection of 50 mg. of heparin: the alpha-2 peak is reduced to normal
size, and a new peak has appeared in front of the albumin peak.
Fin. 3. Electrophoretic patterns of the plasma of Patient 4 with idiopathic hyperlipemia.
Left, native plasma. The alpha-2 and beta-i peaks are elevated as one inseparable peak.
Right, plasma fifteen minutes after the intravenous injection of 50mg. of heparin: the alpha-
2 and beta-i peaks have been reduced to normal size and a new peak has appeared in front
of the albumin peak.
the electrophoretic run, the duration of which is fifty minutes, revealed that the
albumin peak first became apparent after about twenty minutes (Figure 4b).
High speed centrifugation of the plasma (at 18,000 revolutions per minute for
one hour) carried out in 3 patients (cases 1, 2 and 3) caused a decrease in the size
of the prea1bumin peak of the electrophoretic pattern but it did not abolish it.
The peak no longer had a jagged appearance because centrifugation had removed
A a1o,$u$2y Aa1a2$1$gy
Aa1a2$1/32 7 y
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FIG. 4. Electrophoretic patterns of the plasma of Patient 1 with idiopathic hyperlipemia,
taken fifteen minutes after the intravenous injection of 50 mg. of heparin. The photos show
the patterns during the process of electrophoretic migration and are taken at intervals of
ten minutes. The pre-albumin first becomes apparent in the photo taken after 20 minutes.
The last photo shows the completed pattern taken after 50 minutes.
Fin. 5. Electrophoretic patterns of the plasma of Patient 1 with idiopathic hyperlipemia,
taken fifteen minutes after the intravenous injection of 50 mg. of heparin and subjected to
high speed centrifugation. The photos are taken twenty, forty and fifty minutes after the
beginning of the electrophoretic migration. Even after high speed centrifugation a pre-
albumin peak is present, although it is smaller and smoother than in the native plasma (see
Figure 3).
a large proportion of the ehylomicra from the plasma. Instead, it appeared as a
rounded elevation (Figures 5b and e). Its size in the three patients in whom an
eleetrophoretie analysis was carried out after high speed centrifugation (cases 1,
2 and 3) was 6.4, 5.7 and 4.8 per cent of the total protein, respectively. Again,
the peak was first visualized about 20 minutes after the beginning of the electro-
A y A a1c2fift2y A a1a2$,$2y
A a1 A a1a2flfi1 y
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phoretic run (Figure 5a). The plasma of one patient (case 6), after high speed
centrifugation, was placed in a separative electrophoresis cell and the material
in the pre-albumin peak was isolated. Chemical analysis revealed the presence
of considerable amounts of cholesterol and phospholipids in it. Although the
material was, of course, considerably diluted by the buffer solution it contained
28.4 mg. of cholesterol and 43.5 mg. of phospholipids per 100 ml.
Rotation with cold ethyl ether of the plasma obtained after the intravenous
injection of heparin was carried out in 3 patients for the purpose of extracting
lipids. This procedure abolished the pre-albumin peak of the electrophoretic
pattern in all 3 patients proving that this peak contained a large proportion of
lipids.
The values for turbidity in the plasma decreased in all 7 patients following the
intravenous injection of heparin. However, the decrease was slight in 3 patients,
amounting to less than 2 units; moderate in 3 patients, amounting to 4 to 6
units; and pronounced only in 1 patient (case 5) in whom the decrease at three
different times amounted to 14, 25 and 43 units, respectively (Table 3). In the
latter patient, as will be presently shown, the heparin also caused a much greater
decrease in the amounts of lipids in the plasma than in the other patients.
Comparison of the amounts of the various lipids in the plasma before and after
the injection of heparin revealed a decrease in cholesterol and phospholipids in
every one of the 7 patients; and a decrease in neutral fat in 5 of the 7 patients
(cases 2, 3, 4, 5 and 7) (Table 3). Although the decrease in the various lipids
and in the turbidity was relatively small in all but 1 patient (case 5) the regu-
larity with which it occurred makes the decrease a significant observation.
Excepting the one patient (case 5) in whom the lipids and the turbidity decreased
markedly, the average cholesterol decreased from 663 to 576 mg. per 100 ml.;
the average total phospholipids from 658 to 602 mg.; and the average neutral
fat from 1,812 to 1,665 mg. The decrease in cholesterol was in some patients
predominantly in the free cholesterol, and in others in the esterified cholesterol.
In the one patient (case 5) in whom the amounts of the various lipids and the
degree of turbidity decreased considerably heparin was injected on three oc-
casions. The average of these three tests showed a decrease of the cholesterol
from 592 to 312 mg. per 100 ml. of plasma; of the phospholipids from 564 to 313
mg.; and of the neutral fat from 4,900 to 3,049 mg.
Fractionation of the plasma proteins before and after the intravenous injection
of heparin were carried out in 3 patients. In all of them the cholesterol and the
phospholipids decreased in the alpha-i as well as the beta-i lipoprotein fraction
following the injection of heparin (Table 3). On the other hand, the values for
alpha-i, alpha-2, and beta glycoprotein, measured as protein-bound hexose, did
not change.
DISCUSSION
The intravenous injection of 50 or 100 mg. of heparin caused changes in the
electrophoretic pattern in 2 of the 7 normal individuals, in 6 of the 8 patients
with primary hypercholesteremic xanthomatosis and in 6 of the 7 patients with
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idiopathic hyperlipemia. The change consisted of an increase in the speed of
migration of beta-i lipoprotein in all three groups, since the increase in the
size of the alpha-2 peak in the native plasma of idiopathic hyperlipemia is also
dne to beta-i lipoprotein, as chemical fractionation has shown (9). In the 2
normal persons in whom the pattern changed the decrease in the beta-i peak was
compensated by an increase in the size of both the alpha-i and albumin peaks in
one, and by an increase in the size of the alpha-2 peak in the other. In the 6
patients with primary hypercholesteremic xanthomatosis who showed changes
in the electrophoretic pattern the decrease in the beta-i peak was compensated
by an increase in either the alpha-2 peak, the albumin peak or both of these
peaks, and never in the alpha-i peak, as in one of the normal individuals. The
most striking change was observed, however, in 6 of the 7 patients with idio-
pathic hyperlipemia in whom the injection of heparin caused a shift of the beta-i
lipoprotein contained in the elevation of the alpha-2 and beta-i peaks to a new
position ahead of the albumin. This is so far the only known instance in the elec-
trophoretic analysis of human plasma at the standard pH of 8.6 that a component
has been observed to migrate faster in the electric field than albumin.
The most likely reason for the increase in the speed of migration of the beta-i
lipoprotein is its combination with heparin. One may assume that heparin which
has a high negative net charge combines with the beta-i lipoprotein, neutralizes
some of its positive charges and thus increases the effect of its negative charges
thus leading to an acceleration in the speed of its electrophoretic migration. in
idiopathic hyperlipemia in which much of the excess beta-i lipoprotein already
in the native plasma migrates faster than normal beta-i lipoprotein, i.e., with the
speed of alpha-2, the heparin increases the effective negative net charge to such
an extent that most of the beta-i lipoprotein migrates faster even than albumin.
The degree of turbidity did not change significantly following the injection of
heparin in the plasma of the normal individuals or of the patients with primary
hypercholesteremic xanthomatosis since it was clear anyway. However, in the
turbid plasma of the patients with idiopathic hyperlipemia the degree of tur-
bidity decreased in every instance, although slightly only, except in one patient
(case 5) in whom the decrease was considerable.
The various lipid fractions, cholesterol, phospholipids and neutral fat, showed
no significant changes in the normal individuals following the injection of
heparin. In the patients with primary hypercholesteremic xanthomatosis only
the total cholesterol showed consistently a decrease which in 4 of the 8 patients
exceeded 20 mg. per 100 ml. in idiopathic hyperlipemia all 7 patients showed a
decrease in cholesterol and phospholipids and 5 showed a decrease in neutral fat.
However, the decrease in these substances was only moderate in all but I patient
(case 5). The latter patient stood out from our other patients with idiopathic
hyperlipemia in many aspects: First, he was the only one with attacks of upper
abdominal pain (see Part i (8)); second, his plasma contained the largest amount
of neutral fat and thus had a much higher turbidity values than the others. Third,
the lipids in his plasma, after high speed centrifugation, decreased to values
far more below normal, while in the other patients they decreased much less, to
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either normal or still elevated values; and accordingly, after high speed centrifu-
gation the electrophoretic pattern in this patient appeared normal while in the
others the previously elevated peaks had decreased only partially. Fourth, he was
the only patient with idiopathic hyperlipemia in whom, following the injection
of heparin, no pre-albumin component was noted in the electrophoretic pattern.
And, finally, the decrease in lipids in this patient's plasma, after heparin, was
much greater than in the other patients and was indeed remarkable. Fifteen
minutes after the injection of heparin, the neutral fat in the plasma decreased,
on the three occasions of testing, by 2,315, 1,289 and 1,950 mg. per 100 ml.,
respectively. (That is up to 23 grams per liter of plasma or, with a calculated
plasma volume of 2,450 ml., 56 grams.) The great decrease of lipids in this patient
after high speed centrifugation and after the injection of heparin would suggest
that in him the lipids were more loosely bound to proteins than either in normal
individuals or in the other patients with idiopathic hyperlipemia. It is possible
that heparin, rather than causing an increase in the negative charges of the
excess lipids, caused their detachment from proteins and their removal from the
blood into the tissue; and that in this way no pre-albumin component formed
in the post-heparin electrophoretic pattern in this patient.
The effects of heparin on the electrophoretic pattern and on the plasma lipids
in some normal individuals, in most patients with primary hypercholesteremic
xanthomatosis and in all patients with idiopathic hyperlipemia are of con-
siderable interest and possibly of practical value. Neither of the two diseases can
be regarded as harmless since in both coronary heart disease may occur quite
early in adult life (8). It is generally admitted that a diet low in fat is of very
limited value in primary hypercholesteremic xanthomatosis; and although a
diet low in fat reduces the elevated lipid values in idiopathic hyperlipemia (8) the
reduction is only partial and it is often difficult for the patient to adhere to the
diet for long periods of time. It would, therefore, be most encouraging if it were
possible by prolonged therapy with heparin to bring about a prolonged reduction
in the amounts of the plasma lipids. Such studies are now in progress. They are
analogous to those carried out by Graham and co-workers (7) in patients with
atherosclerosis. Good results are anticipated especially in patients with idio-
pathic hyperlipemia because the primary disturbance in that disease seems to be,
according to Thannhauser and Stanley's experiments (10), a defective removal
of lipids from the blood.
SUMMARY
1. An intravenous injection of 50 to 100 mg. of heparin caused a change in
the appearance of the electrophoretic pattern in 2 of 7 normal individuals, in 6 of
8 patients with primary hypercholesteremic xanthomatosis and in 6 of 7 patients
with idiopathic hyperlipemia. In all the change consisted of an increase in the
speed of electrophoretic migration of some of the beta-i lipoprotein: the beta-i
lipoprotein migrated with the speed of either alpha-2, alpha-i or albumin in the
normal individuals and in the patients with primary hypercholesteremic
xanthomatosis; while in the patients with idiopathic hyperlipemia the excess
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beta-i lipoprotein, which even in the native plasma migrated largely with the
speed of alpha-2, migrated, after the injection of heparin, faster even than
albumin.
2. The pre-albumin component in the electrophoretic pattern of the post-
heparin plasma of idiopathic hyperlipemia decreased in size following high speed
centrifugation and disappeared following extraction of the plasma with ether.
Chemical analysis of the pre-albumin component revealed the presence of signifi-
cant amounts of cholesterol and phospholipids. One may assume that a combina-
tion of heparin with lipoprotein occurred and resulted in an increase in the
negative net charge of the latter and thus in an increase in the speed of
electrophoretic migration.
3. The degree of turbidity of the plasma decreased following the injection
of heparin in all patients with idiopathic hyperlipemia, although the decrease
was slight in all but one patient.
4. The amounts of lipids in the plasma did not change significantly in the
normal individuals after the injection of heparin. In the patients with primary
hypercholesteremic xanthomatosis the amount of cholesterol decreased, while in
the patients with idiopathic hyperlipemia not only the cholesterol, but also the
phospholipids and usually also the neutral fat decreased. Although the decrease
was in most patients fairly small in one patient with idiopathic hyperlipemia the
decrease in neutral fat, fifteen minutes after the injection of heparin, amounted
to 2,315 mg. per 100 ml.
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DISCUSSION
DR. FREDERICK URBACH, Philadelphia, Pa.: Dr. Lever's extremely interesting
paper is particularly disturbing to me, having been interested in the study of
these diseases, because it will necessitate the re-evaluation of our concepts of
Essential Familial Xanthomatosis and its relationships to fat metabolism.
Until this time it has been considered that one of the sine qua non's for the diag-
nosis of xanthoma tuberosum is that the patient have clear plasma and a rela-
tively normal serum neutral fat level. I have had the opportunity to go over Dr.
Lever's data and to see the photographs of his patients. Certainly I would
agree that clinically 5 of the 7 patients which he considers according to ,bio-
chemical studies, as hyper-lipemics, would be diagnosed as having xanthoma
tuberosum. The disturbing feature of Dr. Lever's presentation, is that these 5
hyperlipemic patients differ markedly from the description of the forty-one
cases of Familial Essential Hyperlipemia so far reported. These latter patients
have had eruptive xanthomata that appeared very quickly and responded
rapidly to moderate restriction of dietary fat. The problem of increase of neutral
fat in the serum is more than academic biochemical quibbling about minor
differences, but is very important in the consideration of the prognosis of such
patients. As far as we know, patients with hyperlipemia of the originally de-
scribed type do not develop premature or severe atherosclerosis. The disease is
very easily controllable by moderate fat restriction. On the other hand, Es-
sential Familial Xanthomatosis is a serious disease in that almost all patients
develop early and severe vascular sclerosis and are very difficult to treat. This
then poses a practical as well as a theoretical question.
The point about Dr. Lever's observation which is most disturbing to me is
that, as far as I know, no similar mixed forms of chemical hyperlipemia and clini-
cal xanthoma tuberosum have been reported. Since Pincus and Pick discovered
the relationship of hypercholesteremia to xanthoma tuberosum, some 150—200
patients with xanthoma tuberosum have been reported in the literature. Most
of these patients had very careful clinical and biochemical studies. Wile, Wilker-
son, Thannhauser and others examined whole family groups with this disorder.
These investigators, as well as ourselves in a long term study of fourteen pa-
tients have never noted a significant elevation of serum neutral fat level. That
Dr. Lever found an elevation of serum fat levels in 40 % of seventeen patients
with xanthoma tuberosum, while in the preceding thirty-five year period not one
such case was noted out of about two hundred, is most disturbing. I do not wish
to imply that Dr. Lever's chemical studies are by any means at fault. I have
examined the data, and do not believe that there is any possibility of error in
the methods or results. Dr. Lever's paper is unquestionably most important,
since it opens up a completely new approach to a most interesting and challenging
problem. The other point that I would like to ask Dr. Lever about is that, to the
best of my knowledge, no one has ever noted a plasma protein that has moved
faster in electrophoretic patterns than albumin. I wonder whether he has any
explanation as to the very peculiar peak appearing ahead of the albumin peak
after heparin therapy.
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DR. HAMILTON MONTGOMERY, Rochester, Minn.: I know that Thannhauser
and I have differed about grouping certain cases of xanthoma, whether they
were essential or primary. I do believe that in xanthoma tuberosum, as such
whether there is a familial history or not, namely xanthoma involving the ex-
tensor surfaces, elbows and knees, etc. one will in 95 per cent of the cases find
increase in cholesterol and a relative increase in total lipids. The older concept,
as I published it with Dr. Osterberg in 1937, where we talked about fatty acids,
Thannhauser and Lever have broken down into the neutral fats, as well as the
fatty acids. That is probably quite important. In the group of cases, as yet un-
published, of xanthoma of the eyelids alone, elevated blood lipids occurred in
about 50 per cent of the cases and of that 50 per cent or 25 per cent of the total
in rough figures had evidence of cardiovascular disease.
DR. ARTHUR C. CURTIS, Ann Arbor, Michigan: My experience has been the
same as Dr. Urbach's in so far as idiopathic hyperlipemia is concerned in that the
xanthomas are of the eruptive or secondary type. Also in my experience if these
people are put on a simple reduction diet, the xanthomas disappear with the fall
of lipemia. I can conceive how a person could have idiopathic hyperlipemia with
or without eruptive xanthoma for a long enough time to develop angina pectoris
and coronary occlusion similar to that seen in primary hypercholesteremic
xanthomatosis or arteriosclerosis. Dr. Lever's study is most instructive. The
changes he noticed in alpha two and beta one of the electrophoretic pattern of
these patients brings up the question of whether these lipoproteins are similar
to the Sf 10—20 Gofman bodies?
DR. THEODORE CORNBLEET, Chicago, Ill.: Relative to the discussion on
heparin, it is interesting that in the rabbit, an animal easily subject to cholesterol
feeding damage, there are few mast cells scattered throughout its tissues. By
contrast, the rat, notoriously resistant to such injury, is richly provided with
mast cells.
DR. FRED D. WEIDMAN, Philadelphia, Pa.: Of course, the circulating blood is
a natural first thought when it comes to investigative problems like this, with all
the enzymatic possibilities that there are in it and which could account theo-
retically, and no doubt do, for changes in the fractions of the lipoproteins. It is
necessary, though, to go somewhat farther back than that. The substances which
are worked upon in circulating blood do not originate in it (unless one considers
the possibility of lining endothelium cells). Into the circulating blcod are poured
the products of intermediary metabolism. All of this is obvious, but I state
it in order to lead into one of the more obscure fountain heads, namely the
lymph vascular system, speaking of it in its broader sense and including the great
reservoirs such as the peritoneal cavity and pleura, and, in respect to xantho-
matous processes, the tendon sheaths.
At necropsies I have been impressed by the different quality of the lymphatic
juice in tendon sheaths; its glariness or opalescence. Perhaps this is significant
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in that xanthomas frequently elect tendon sheaths for their localization and it is
largely on this basis that I have often wondered whether there is normally a
lipoprotein component in tendon sheaths; physiologists told us long ago that the
composition of the lymph varies tremendously in different parts of the body.
Of course, it would be difficult from the practical standpoint to collect samples
of materials from tendon sheaths in man, but it is easy to produce hyper-
cholesterolemia in rabbits. I simply offer this as a lead yet farther back than the
circulating blood in the genesis of these normal and abnormal lipoproteins.
It would be intriguing indeed if one could compare the composition of tendon
sheath lymph in xanthomas with that of non-xanthomatous subjects.
DR. WALTER F. LEVER, (in closing): In answer to Dr. Urbach's question,
I do not believe it likely that a mistake could have occurred in the differentiation
between idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis
since we did not rely merely on an inspection of the serum to decide whether it
was clear or milky,—although this alone proved entirely adequate for the differ-
entiation of the two diseases. We employed three laboratory procedures for differ-
entiation: first, measurement of the degree of turbidity of the plasma by color-
imeter; second, determination of the amount of neutral fat which is normal in
primary hypercholesteremic xanthomatosis and greatly increased in idiopathic
hyperlipemia; and third, electrophoretic analysis which shows a different pattern
in the two diseases since primary hypercholesteremic xanthomatosis shows an
elevation only of the beta-i peak while idiopathic hyperlipemia shows an eleva-
tion either of the alpha-2 peak alone or of both the alpha-2 and beta-i peaks.
Dr. Urbach asked for the reason why heparin causes an increase in the speed
of electrophoretic migration of the lipoprotein present in the elevated peaks of
both diseases. The most likely explanation is that heparin combines with the
lipoprotein. Since heparin possesses a high negative charge it would raise the
negative net charge of the lipoprotein and thus increase its speed of migration.
As far as Dr. Montgomery's question is concerned, it is important not to
think in terms of total lipids but to define which lipid is elevated. There are three
different lipids: cholesterol, phospholipids and neutral fat, and the important
question is whether there is an elevation only of the cholesterol and phospho-
lipids, as in primary hypercholesteremic xanthomatosis, or an elevation also of
the neutral fat, as in idiopathic hyperlipemia. We determined the amount of
neutral fat in the plasma by determining first the amount of total fatty acids
and then subtracting from the total fatty acids those fatty acids that are com-
bined with cholesterol and phospholipids, leaving as the rest the fatty acids of
neutral fat.
Dr. Curtis' questions may be answered that in two of our patients with idio-
pathic hyperlipemia the tuberous xanthomata developed long before the eruptive
xanthomata did. These tuberous xanthomata proved very persistent. In one
patient the first tuberous xanthoma appeared at the age of eight and was still
present at the latest examination, at the age of 42.
As far as a relation of our studies to those of Gofman is concerned, McGinley,
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Jones and Gofman (J. Invest. Dermat. 19: 71, 1952) have studied in patients with
xanthomatous lesions by means of the ultracentrifuge the same substance, namely
beta-i lipoprotein, that we found by electrophoresis to be present in abnormally
high concentration. These authors observed in patients with xanthomatous
lesions a great increase in the concentration of those beta-i lipoproteins having
flotation rates between Sf 10 and 40.
I cannot comment on Dr. Cornbleet's statement concerning mast cells because
we have not done any studies along these lines. I should like to say in regard to
Dr. Weidman's comment that it is much easier to induce by means of a low-fat
diet a decrease in the amounts of plasma lipids in idiopathic hyperlipemia than
in primary hypercholesteremic xanthomatosis. This suggests a different etiology
for the two diseases. Thannhauser (Tr. A. Am. Phys. 62: 245, 1949) probably is
correct in his belief that in idiopathic hyperlipemia the primary fault lies in an
inadequate transport of the lipids from the blood stream into the tissue; whereas
primary hypercholesteremic xanthomatosis represents an inborn metabolic error
in which there is an overproduction of cholesterol and phospholipids.
ANNOUNCEMENT
A special international award, to consist of a bronze medal and a scroll, is
planned to honor outstanding workers in the field of the venereal diseases and
non-venereal treponematoses. Provided sufficient funds can be collected to
guarantee an annual award out of interest on a special fund, this award will be
administered by the World Health Organization, in a manner similar to WHO's
administration of the Darling Award for outstanding achievements in malaria
control.
Since this is to be an international award, funds are being sought from inter-
ested persons and organizations throughout the world. Individuals and organiza-
tions in the United States are invited to contribute toward the establishment of
this special fund. Checks should be made out to "THE INTERNATIONAL TEEPO-
NEMATOSIS AWARD FUND", and sent to the temporary custodian of funds col-
lected in the United States, Dr. Frank W. Reynolds, The Saratoga Spa, Saratoga
Springs, N. Y.
